ACHL - long - catalyst - recent high vol.Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
This is not a financial advice!
2 upcoming catalysts on 31st of March
ER is on 27th of February - keep in mind
Pretty high volume recently
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
We might see a little PB to around 1.10 -1.20 where is a good entry zone - another scenario is that we break the 1.45 zone without any PB.
Keep an eye on 1.80, 2.40 and 2.90 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 0.90
TP approx. 3.40
Most info on the chart.
Trade carefully!
